Related references
Note: Only part of the references are listed.Galangin 3-benzyl-5-methylether derivatives function as an adiponectin synthesis-promoting peroxisome proliferator-activated receptor γ partial agonist
Hyejin Ko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2022)
Adiponectin and leptin in the diagnosis and therapy of NAFLD
Chrysoula Boutari et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Endolichenic fungi: A hidden source of bioactive metabolites
Shivankar Agrawal et al.
SOUTH AFRICAN JOURNAL OF BOTANY (2020)
PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
Yaping Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Discovery and Structure-Activity Relationships of Novel Template, Truncated 1′-Homologated Adenosine Derivatives as Pure Dual PPARγ/δ Modulators
Seungchan An et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Toxicological effects of urban particulate matter on corneal and conjunctival epithelial cells
Soo-Wang Hyun et al.
TOXICOLOGICAL RESEARCH (2020)
Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches
Kazuishi Kubota et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)
2-Phenyl-8-(1-phenylallyl)-chromenone compounds have a pan-PPAR modulator pharmacophore
Sungjin Ahn et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Dual conformation of the ligand induces the partial agonistic activity of retinoid X receptor α (RXRα)
Yurina Miyashita et al.
FEBS LETTERS (2019)
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Konstantinos Avgerinos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
2-Formyl-komarovicine promotes adiponectin production in human mesenchymal stem cells through PPAR gamma partial agonism
Sungjin Ahn et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Secondary metabolism in the lichen symbiosis
Mark J. Calcott et al.
CHEMICAL SOCIETY REVIEWS (2018)
Mbandakamine-Type Naphthylisoquinoline Dimers and Related Alkaloids from the Central African Liana Ancistrocladus ealaensis with Antiparasitic and Antileukemic Activities
Dieudonne Tshitenge Tshitenge et al.
JOURNAL OF NATURAL PRODUCTS (2018)
Kojyl cinnamate esters are peroxisome proliferator-activated receptor alpha/gamma dual agonists
Sae On Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Investigation of the hydrogen bond donating ability of 1,8-naphthalenediol by NMR spectroscopy and its use as a hydrogen bonding catalyst
Yunus Emre Turkmen
TURKISH JOURNAL OF CHEMISTRY (2018)
Polypharmacology of N6-(3-lodobenzyl)adenosine-5′-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic Potential
Jinha Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Dioncophyllines C2, D2, and F and Related Naphthylisoquinoline Alkaloids from the Congolese Liana Ancistrocladus ileboensis with Potent Activities against Plasmodium falciparum and against Multiple Myeloma and Leukemia Cell Lines
Jun Li et al.
JOURNAL OF NATURAL PRODUCTS (2017)
Opportunities and challenges in phenotypic drug discovery: an industry perspective
John G. Moffat et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ
Chyuan-Chuan Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Endolichenic Fungi: A Hidden Reservoir of Next Generation Biopharmaceuticals
Brahma N. Singh et al.
TRENDS IN BIOTECHNOLOGY (2017)
Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs
Min A. Lee et al.
SCIENTIFIC REPORTS (2017)
ImageJ2: ImageJ for the next generation of scientific image data
Curtis T. Rueden et al.
BMC BIOINFORMATICS (2017)
SR2067 Reveals a Unique Kinetic and Structural Signature for PPARγ Partial Agonism
Laura M. van Marrewijk et al.
ACS CHEMICAL BIOLOGY (2016)
Nuclear receptors and nonalcoholic fatty liver diseases
Matthew C. Cave et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus
Abd A. Tahrani et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin
Md. Murad Hossain et al.
LIFE SCIENCES (2015)
Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism
Alice J. Kroker et al.
PPAR RESEARCH (2015)
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease
Amirhossein Sahebkar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Computational and DNMR Investigation of the Isomerism and Stereodynamics of the 2,2′-Binaphthalene-1,1′-diol Scaffold
Andrea Mazzanti et al.
JOURNAL OF ORGANIC CHEMISTRY (2014)
Identification of a New RXRα Antagonist Targeting the Coregulator-Binding Site
Fan Chen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Molecular mechanism of 9-cis-retinoic acid inhibition of adipogenesis in 3T3-L1 cells
Chiaki Sagara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Molecular Mechanism of Peroxisome Proliferator-Activated Receptor α Activation by WY14643: a New Mode of Ligand Recognition and Receptor Stabilization
Amanda Bernardes et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Target identification and mechanism of action in chemical biology and drug discovery
Monica Schenone et al.
NATURE CHEMICAL BIOLOGY (2013)
Lichens: a promising source of antibiotic and anticancer drugs
Gajendra Shrestha et al.
PHYTOCHEMISTRY REVIEWS (2013)
Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
Li-Song Zhang et al.
PLOS ONE (2012)
PPARs at the crossroads of lipid signaling and inflammation
Walter Wahli et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
PPARs and Lipid Ligands in Inflammation and Metabolism
Gregory S. Harmon et al.
CHEMICAL REVIEWS (2011)
Epigenetic codes of PPARγ in metabolic disease
Shigeki Sugii et al.
FEBS LETTERS (2011)
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies
Yoon Kong Loke et al.
BRITISH MEDICAL JOURNAL (2011)
The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
Sandeep Tyagi et al.
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH (2011)
Rosiglitazone Revisited An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality
Steven E. Nissen et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Brown vs white adipocytes: The PPARγ coregulator story
Arjen Koppen et al.
FEBS LETTERS (2010)
Steroid Receptor Coactivator (SRC) Family: Masters of Systems Biology
Brian York et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses
J. Hoppmann et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Cross-Talk between PPARs and the Partners of RXR: A Molecular Perspective
Lap Shu Alan Chan et al.
PPAR RESEARCH (2009)
Metabolic Actions of Estrogen Receptor Beta (ERβ) are Mediated by a Negative Cross-Talk with PPARγ
Anna Foryst-Ludwig et al.
PLOS GENETICS (2008)
Partial agonists activate PPARγ using a helix 12 independent mechanism
John B. Bruning et al.
STRUCTURE (2007)
Regiolone from the pericarps of Juglans regia L.
Jun-Xi Liu et al.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS (2007)
Retinaldehyde represses adipogenesis and diet-induced obesity
Ouliana Ziouzenkova et al.
NATURE MEDICINE (2007)
Metabolites from the endophytic fungus Nodulisporium sp firom Juniperus cedre
Jingqiu Dai et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2006)
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Takashi Kadowaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Mechanisms of disease: Retinoid X receptor heterodimers in the metabolic syndrome
AI Shulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Nuclear hormone receptor coregulator: Role in hormone action, metabolism, growth, and development
MA Mahajan et al.
ENDOCRINE REVIEWS (2005)
1-(2,6-dihydroxyphenyl)butanone
HR Huang et al.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS (2005)
Troglitazone and liver injury: In search of answers
M Chojkier
HEPATOLOGY (2005)
Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor γ (PPARγ)-interacting protein, is required for PPARγ- mediated adipogenesis
C Qi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix
RT Gampe et al.
GENES & DEVELOPMENT (2000)
Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR
YJ Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Asymmetry in the PPAR gamma/RXR alpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors
RT Gampe et al.
MOLECULAR CELL (2000)
Share Paper
